(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one

C96H115F2N29O9 — CID 161033190

IUPAC(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one
SMILESC=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CC4(F)F)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CCC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CC4CC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CN4CCOCC4)CC3)nc12
InChIInChI=1S/C25H32N8O3.2C24H29N7O2.C23H25F2N7O2/c1-17-18(13-23(34)27-17)12-19-15-26-33-22(28-20-2-3-20)14-21(29-25(19)33)31-4-6-32(7-5-31)24(35)16-30-8-10-36-11-9-30;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-4-5-19)13-20(28-24(18)31)29-6-8-30(9-7-29)23(33)10-16-2-3-16;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-5-6-19)13-20(28-23(18)31)29-7-9-30(10-8-29)24(33)16-3-2-4-16;1-13-14(9-20(33)27-13)8-15-12-26-32-19(28-16-2-3-16)10-18(29-21(15)32)30-4-6-31(7-5-30)22(34)17-11-23(17,24)25/h12,14-15,20,28H,1-11,13,16H2,(H,27,34);2*11,13-14,16,19,27H,1-10,12H2,(H,26,32);8,10,12,16-17,28H,1-7,9,11H2,(H,27,33)/b18-12+;2*17-11+;14-8+
InChIKeyTZWZAVORWFLYLG-HULIEZPHSA-N
MW1857.17 g/mol
LogP7.06
Rot. Bonds22

About (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one

(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one (PubChem CID 161033190) has the molecular formula C96H115F2N29O9 and a molecular weight of 1857.17 g/mol. Its IUPAC name is (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one.

Molecular Properties

Compound Name(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one
PubChem CID161033190
Molecular FormulaC96H115F2N29O9
Molecular Weight1857.17 g/mol
Exact Mass1855.94
IUPAC Name(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one
SMILESC=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CC4(F)F)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CCC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CC4CC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CN4CCOCC4)CC3)nc12
InChIInChI=1S/C25H32N8O3.2C24H29N7O2.C23H25F2N7O2/c1-17-18(13-23(34)27-17)12-19-15-26-33-22(28-20-2-3-20)14-21(29-25(19)33)31-4-6-32(7-5-31)24(35)16-30-8-10-36-11-9-30;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-4-5-19)13-20(28-24(18)31)29-6-8-30(9-7-29)23(33)10-16-2-3-16;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-5-6-19)13-20(28-23(18)31)29-7-9-30(10-8-29)24(33)16-3-2-4-16;1-13-14(9-20(33)27-13)8-15-12-26-32-19(28-16-2-3-16)10-18(29-21(15)32)30-4-6-31(7-5-30)22(34)17-11-23(17,24)25/h12,14-15,20,28H,1-11,13,16H2,(H,27,34);2*11,13-14,16,19,27H,1-10,12H2,(H,26,32);8,10,12,16-17,28H,1-7,9,11H2,(H,27,33)/b18-12+;2*17-11+;14-8+
InChIKeyTZWZAVORWFLYLG-HULIEZPHSA-N
XLogP7.06
TPSA391.95 Ų
H-Bond Donors8
H-Bond Acceptors30
Rotatable Bonds22
Heavy Atoms136
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001857.17
LogP ≤ 57.06
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1030

Analyze (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one?
The IUPAC name of (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one (CID 161033190) is (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one.
What is the SMILES notation for (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one?
The canonical SMILES for (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one is C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CC4(F)F)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)C4CCC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CC4CC4)CC3)nc12.C=C1NC(=O)C/C1=C\c1cnn2c(NC3CC3)cc(N3CCN(C(=O)CN4CCOCC4)CC3)nc12.
What is the InChIKey of (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one?
The InChIKey is TZWZAVORWFLYLG-HULIEZPHSA-N. The full InChI is InChI=1S/C25H32N8O3.2C24H29N7O2.C23H25F2N7O2/c1-17-18(13-23(34)27-17)12-19-15-26-33-22(28-20-2-3-20)14-21(29-25(19)33)31-4-6-32(7-5-31)24(35)16-30-8-10-36-11-9-30;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-4-5-19)13-20(28-24(18)31)29-6-8-30(9-7-29)23(33)10-16-2-3-16;1-15-17(12-22(32)26-15)11-18-14-25-31-21(27-19-5-6-19)13-20(28-23(18)31)29-7-9-30(10-8-29)24(33)16-3-2-4-16;1-13-14(9-20(33)27-13)8-15-12-26-32-19(28-16-2-3-16)10-18(29-21(15)32)30-4-6-31(7-5-30)22(34)17-11-23(17,24)25/h12,14-15,20,28H,1-11,13,16H2,(H,27,34);2*11,13-14,16,19,27H,1-10,12H2,(H,26,32);8,10,12,16-17,28H,1-7,9,11H2,(H,27,33)/b18-12+;2*17-11+;14-8+.
What are the key properties of (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one?
(4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one has a molecular weight of 1857.17 g/mol, XLogP of 7.06, 22 rotatable bonds, 8 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (4E)-4-[[5-[4-(cyclobutanecarbonyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[5-[4-(2-cyclopropylacetyl)piperazin-1-yl]-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2,2-difluorocyclopropanecarbonyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one;(4E)-4-[[7-(cyclopropylamino)-5-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylidenepyrrolidin-2-one is sourced from PubChem (CID 161033190), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).